The Relation between Antioxidant Status and Alterations in Fatty Acid Profile in Patients with Crohn Disease and Controls

References

• Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859–61.
   PubMed Web of Science ®Google Scholar
• Simmonds NJ, Rampton DS. Inflammatory bowel disease—a radical view. Gut 1993;34:865–8.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992;103:177–85.
   PubMed Web of Science ®Google Scholar
• Das UN, Podma M, Sogar PS, Ramesh G, Koratkar R.Stimulation of free radical generation in human leucocytes by various agents including tumor necrosis factor is a calmodulin dependent proces. Biochem Biophys Res Commun 1990;167:1030–6.
   Google Scholar
• Halliwell B. Free radical and antioxidants: a personal view. Nutr Rev 1994;52:253–65.
   PubMed Web of Science ®Google Scholar
• Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabré E, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989;84:744–8.
   PubMed Web of Science ®Google Scholar
• Fernandez-Banares F, Mingorance MD, Esteve M, Cabré E, Lachica M, Abad-Lacruz A, et al. Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status. Am J Gastroenterol 1990;85:1584–9.
   Google Scholar
• Kuroki F, Iida M, Tominaga M, Matsumoto T, Hirakawa K, Sugiyama S, et al. Multiple vitamin status in Crohn’s disease. Correlation with disease activity. Dig Dis Sci 1993;38:1614–8.
   PubMed Web of Science ®Google Scholar
• Hinks LJ, Inwards KD, Lloyd B, Clayton B. Reduced concentrations of selenium in mild Crohn’s disease. J Clin Pathol 1988;41:198–201.
   PubMed Web of Science ®Google Scholar
• Hoffenberg EJ, Deutsch J, Smith S, Sokol RJ. Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr 1997;65:1482–8.
   PubMed Web of Science ®Google Scholar
• Geerling BJ, Badart-Smook A, Stockbrtigger RW, Brummer RJM. Comprehensive nutritional status in patients with longstanding Crohn’s disease in remission. Am J Clin Nutr 1998;67:919–26.
   PubMed Web of Science ®Google Scholar
• Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1991;53:189S–93S.
   Google Scholar
• Kinsella JR, Lokesh B, Broughton S, Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutr 1990;6:24–44.
   PubMed Web of Science ®Google Scholar
• Esteve-Comas M, Ramirez M, Fernandez-Banares F, Abad Lacruz A, Gil A, Cabre E, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992;33:1365–9.
   Google Scholar
• Esteve-Comas M, Nuirez MC, Fernandez-Baüares F, Abad Lacruz A, Gil A, Cabre E, et al. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993;34:1370–3.
   Google Scholar
• Kuroki F, Lida M, Matsumoto T, Aoyagi K, Kanamoto K, Fujishima M. Serum n3 polyunsaturated fatty acid are depleted in Crohn’s disease. Dig Dis Sci 1997;42:1137–41.
   PubMedGoogle Scholar
• Siguel EN, Lerman RH. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 1996;45:12–23.
   PubMed Web of Science ®Google Scholar
• Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K, Vik T. Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipid fatty acid as markers of dietary u.3-fatty acid intake. Am J Clin Nutr 1993;57 Suppl:801s–6s.
   Google Scholar
• Cabré E, Periago JL, Mingorance MD, Fernández-Bañares F, Abad A, Esteve M, et al. Factors related to the plasma fatty acid profile in healthy subjects, with special reference to antioxidant micronutrient status: a multivariate analysis. Am J Clin Nutr 1992;55:831–7.
   Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 Suppl 170:2–6.
   Web of Science ®Google Scholar
• van Hees PA, van Elteren PH, van Lier HJ, van Tongeren JHM. An index of inflammatory activity in patients with Crohn’s disease. Gut 1980;21:279–86.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the qantitative and qualitative characterization of erythrocyte gluthathione peroxidase. J Lab Clin Med 1967;70:158.
   PubMed Web of Science ®Google Scholar
• Horwitt MK, Harvey CC, Dahm CH, Searcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 1972;203:223–36.
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497–509.
   Google Scholar
• Hoving EB, Jansen G, Volmar M, van Doormaal JJ, Muskiet FAJ. Profiling of plasma triglyceride fatty acids as their methyl esters by capillary gas chromatography, preceded by a rapid aminopropyl silica column chromatographic separtion of lipid classes. J Chromatogr 1988;434:395–409.
   Google Scholar
• Kaluzny MA, Duncan LA, Meritt MV, Epps DE. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 1985;26:135–40.
   PubMed Web of Science ®Google Scholar
• Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J Lipid Res 1964;5:600–8.
   PubMed Web of Science ®Google Scholar
• Hornstra G. Essential fatty acids, pregnancy and pregnancy complications: a round table discussion. In: Sinclair A, Gibson R, editors. Essential fatty acids and eicosanoids. Invited papers from the third international congress. Champaign (IL): American Oil Chemistry Society; 1992. p. 177–82.
   Google Scholar
• Holman RT. The ratio of trienoic:tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 1960;70:405–10.
   PubMed Web of Science ®Google Scholar
• Al MDM, Badart-Smook A, v Houwelingen AC, Hasaart THM, Hornstra G. Fat intake of women during normal pregnancy: relationship with maternal and neonatal essential fatty acid status. J Am Coll Nutr 1996;15:49–55.
   Google Scholar
• NEVO Foundation. Dutch food composition table 1989–1990. Voorlichtingsbureau voor de Voeding. The Hague, The Netherlands: The Foundation; 1990.
   Google Scholar
• Aroujo V, Arnal C, Boronat M, Ruiz E, Dominguez C. Oxidant-antioxidant imbalance in blood of children with juvenile rheumatoid arthritis. Biofactors 1998;8:155–9.
   Google Scholar
• Gee MI, Grace MG, Wensel RH, Sherbaniuk RW, Thomson AB. Nutritional status of gastroenterology outpatients: comparison of inflammatory bowel disease with functional disorders. J Am Diet Ass 1985;85:159–9.
   Google Scholar
• Rigaud D, Angel LA, Cerf M, Carduner MJ, Melchior JC, Sautier C, et al. Mechanisms of decreased food intake during weight loss in adult Crohn’s disease patients without obvious malabsorption. Am J Clin Nutr 1994;60:775–81.
   PubMed Web of Science ®Google Scholar
• Cameron ME, Van Staveren WA. Manual on methodology for food consumption studies. Oxford: Oxford University Press; 1988.
   Google Scholar
• Sandström B, Davidsson L, Bosaeus I, Eriksson R, Alpsten M. Selenium status and absorption of zinc (65Zn), selenium (75Se) and manganese (54Mn) in patients with short bowel syndrome. Eur J Clin Nutr 1990;44: 697–703.
   Google Scholar
• Andersson H, Bosaeus I, Brummer R-J, Fasth S, Hulten L, Mangusson O, et al. Nutritional and metabolic consequences of extensive bowel resection. Dig Dis 1986;4:193–202.
   Google Scholar
• Keshavarzian A, Haydek J, Zabihi R, Doria M, D’Astice M, Sorenson JRJ. Agents capable of eliminating reative oxygen species. Dig Dis Sci 1992;37:1866–73.
   Google Scholar
• Millar AD, Rampton DS, Chander CL, Claxson AWD, Blades S, Coumbe A, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996;39:407–15.
   PubMed Web of Science ®Google Scholar
• Reimund JM, Allison AC, Muller CD, Dumont S, Kenney JS, Baumann R, et al. Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn’s disease and ulcerative colitis. Eur J Clin Invest 1998;28:145–50.
   PubMedGoogle Scholar
• Geerling BJ, Van Deursen C, Stockbrügger RW, Brummer RJM. Improved antioxidant status after supplementation with n-3 fatty acids and/or antioxidants in addition to a regular diet in patients with Crohn’s disease in a double blind placebo controlled study. Proceedings of the Spring Meeting of the Dutch Society of Gastroenterology; 1998 March 19–20; Veldhoven, The Netherlands. p. 100.
   Google Scholar
• Geerling BJ, van Houwelingen AC, Badart-Smook A, Stock brügger RW, Brummer R-JM. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn’s disease compared with controls. Am J Gastroenterol 1999;94:410–7.
   Google Scholar
• Gross V, Arndt H, Andus T, Palitzsch KD, Scholmerich J. Free radicals in inflammatory bowel diseases pathophysiology and therapeutic implications. Hep Gastroenterol 1994;41:320–7.
   Google Scholar
• Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Laar A, de Bruin M, et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462–8.
   PubMed Web of Science ®Google Scholar
• Winckler BS, Orselli SM, Rex TS. The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. J Free Rad Biol Med 1994;17:333–49.
   Google Scholar
• Esteve-Comas M, Ramirez M, Fernández-Bañares F, Abad-Larcruz A, Gil A, Cabre E, et al. Determinants of plasma fatty acids abnormalities in patients with active inflammatory bowel disease: a multivariate analysis. Inflamm Bowel Dis 1995;1:95–100.
   PubMedGoogle Scholar
• Mazlam MZ, Hodgson HJF. Why measure C reactive protein? Gut 1994;35:5–7.
   PubMedGoogle Scholar